Zinc levels in prostatic fluid of patients with prostate pathologies;Niveles de zinc en líquido prostático de pacientes con patologías de próstata

Investigacion Clinica

Volumn 48, Issue 3, 2007, Pages 287-294

  Gómez, Yenny ^a   Arocha, Francisco ^b   Espinoza, Fabiola ^b   Fernández, Denny ^c   Vásquez, Aracelis ^c   Granadillo, Víctor ^c  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Hyperplasia; Prostate cancer; Prostatic fluid; Prostatis; Zinc

Indexed keywords

ZINC; BIOLOGICAL MARKER;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; DRUG BLOOD LEVEL; HUMAN; PROSTATE CANCER; PROSTATE FLUID; PROSTATE HYPERTROPHY; PROSTATITIS; ADENOCARCINOMA; ADULT; AGED; BODY FLUID; CHEMISTRY; COMPARATIVE STUDY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; PROSTATE; PROSTATE TUMOR;

ADENOCARCINOMA; ADULT; AGED; BIOLOGICAL MARKERS; BODY FLUIDS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; ZINC;

EID: 38149033737     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McNeal, J. Normal and pathologic anatomy of prostate. Urology 1981; (Suppl 17):328-336.
2. Abrams P, Blaivas J, Stanton S, Andersen J. Standardization of terminology of lower urinary tract function. Scand J Urol Nephrol 1988; 114:5-19.
3. Thomas T, Plymat K, Blannin J, Meade T. Prevalence of urinary incontinence. Br Med J 1980; 281:1243-1245.
4. King J. Assessment of zinc status. J Nutrition 1990; 120:1474-1479.
5. Jackson M. Physiology of zinc: general aspects. In Mills C, ed. Zinc in human biology. London: Springer-Verlag, 1989.
6. Feng P, Liang J, Li T, Guan Z, Zou J, Costello L. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2000; 4(1):31-36.
7. Elzanaty S, Malm J, Giwercman A. Viscoestity of seminal fluid in relation to the epididymal and accessory sex gland function and its impact on sperm motility. Int J Andrology 2004; 27(2):94-96.
8. Vera-Gil A, Pérez Castejon M, Barral M, Recreo P. Location of zinc in the testicle rat. Acta Anat (Basel) 1991; 141(1):70-73.
9. Huang J, Chang L. Intracellular effect of ventral prostate in zinc deficient rats. Chung Huang I Hsueh Tsa Chih 1992; 49(4); 238-243.
10. Minetti C, Oshiro M, Santos M, Romaldini J, Moura N, Valle L, Olivera-Filho R. Androgenic expression in the submandibular gland of zinc-deficient mice. Ann Nutri Metabol 1992; 36(3):167-174.
11. Hunt C, Johnson P, Herbel J, Mullen L. Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men. Am J Clin Nut 1992; 56(1):148-157.
12. Liang J, Liu Y, Zou J, Franklin R, Costello L, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40(3):200-207.
13. Kavanagh J. Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J Reprod Fertil 1985; 75(1):35-41.
14. Cho Y, Lee S, Lee J, Kim S, Kim J, Lee W, Yoon M. Changes in serum and prostatic zinc concentrations in rats after intraprostatic injection of zinc: comparison of two forms of zinc delivery. Int J Urol 2002; 9(12):681-687.
15. Thorburn-Wright E, Chmiel JS, Grayhack JT, Schaeffer AJ. Prostatic fluid inflammation in prostatitis. J Urol 1994; 152:2300-2303.
16. Bataineh Z. Zinc in normal and pathological human prostate gland. Saudi Med J 2002 Feb; 23(2):218-220.
17. Youmans G, Lyman R. The bactericidal action of prostatic fluid in dogs. J Infec Dis 1998; 62:117-121.
18. Fair W, Heston W. The relationship of bacterial prostatic and zinc. Prog Clin Biol Res 1977; 14:129-142.
19. Hamer D. Metallothionein. Ann Rev Biochem 1986; 55:913-951.
20. Mitterauer T, Nanoff Ch, Ahorn H, Freissmuth M, Hohenegger M. Metal dependent nucleotide binding to the Escherichia coli rotamase SlyD. Biochem J 1999; 342:33-39.
21. Nanavaty J, Mortensen J, Shryock T. The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli. Curr Microbiology 1998;:36(4):212-215.
22. Schaeffer A. Diagnosis and treatment of prostatic infections. Urology 1990; (Suppl 36) 13: 2-13.
23. Liang J, Liu Y, Zou J, Franklin R, Costello L, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40(3):200-207.
24. Aoyagi, K, Shima I, Wang, I, Hu Y, Garcia F, Stears M. Specific Transcriptotion Factors Prognostic for Prostate Cancer Progression. Clin Cancer Res 1998; 4:2153-2160.
25. Brys M, Nawrocka AD, Miekos E, Zydek C, Foksinski M, Berecki A, Krajewska W. zinc and cadmium analysis in human prostate neoplasmas. Biol Trace Element Res 1997; 59(1-3):145-152.
26. Zaichick V, Sviridova T, Zaichick S. Zinc in the human prostate gland: normal, hyperplasic and cancerous. Int Urol Nephrol 1997; 29(5):565-574.
27. Fahim M, Fahim Z, Der R. Zinc treatment for the reduction of hyperplasia of the prostate. Fed Proc 1976; 35:361-368.
28. Lagiou P, Trichopoulou A, Hsieh C, Adami H, Trichopoulou D. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999; 54(2):284-290.
29. Andro M, Riffaud J. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 year of published experience. Curr Ther Res 1995; 56: 796-817.
30. Vartsky D, Shilstein S, Bercovich A, Huszar M, Breskin A, Chechik R, Korotinsky S, Malnick D, Moriel E. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value. J Urol 2003; 170(6): 2258-2262.